Direct Flow gets FDA OK for aortic heart valve study

05/21/2013 |

The FDA has given Direct Flow Medical the go-ahead to launch a feasibility study of its Transcatheter Aortic Heart Valve System, which consists of a distinctive metal-free heart valve implanted transfemorally using a flexible, 18-French delivery device. The trial will involve 30 aortic stenosis patients from as many as six clinical sites in the U.S.

View Full Article in:

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ